MX360120B - Produccion de virus infecciosos de influenza. - Google Patents
Produccion de virus infecciosos de influenza.Info
- Publication number
- MX360120B MX360120B MX2015001499A MX2015001499A MX360120B MX 360120 B MX360120 B MX 360120B MX 2015001499 A MX2015001499 A MX 2015001499A MX 2015001499 A MX2015001499 A MX 2015001499A MX 360120 B MX360120 B MX 360120B
- Authority
- MX
- Mexico
- Prior art keywords
- production
- influenza viruses
- infectious influenza
- infectious
- relates
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 4
- 230000002458 infectious effect Effects 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 241000712461 unidentified influenza virus Species 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000005215 recombination Methods 0.000 abstract 2
- 230000006798 recombination Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00051—Methods of production or purification of viral material
- C12N2760/00052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16164—Methods of inactivation or attenuation by serial passage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16261—Methods of inactivation or attenuation
- C12N2760/16264—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305968 | 2012-08-03 | ||
| PCT/EP2013/065920 WO2014019990A1 (en) | 2012-08-03 | 2013-07-29 | Production of infectious influenza viruses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015001499A MX2015001499A (es) | 2015-08-20 |
| MX360120B true MX360120B (es) | 2018-10-23 |
Family
ID=48900986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015001499A MX360120B (es) | 2012-08-03 | 2013-07-29 | Produccion de virus infecciosos de influenza. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9982240B2 (OSRAM) |
| EP (1) | EP2880154B1 (OSRAM) |
| JP (1) | JP6335167B2 (OSRAM) |
| KR (1) | KR20150038374A (OSRAM) |
| CN (1) | CN104704112A (OSRAM) |
| AU (1) | AU2013298632B2 (OSRAM) |
| BR (1) | BR112015002268A2 (OSRAM) |
| CA (1) | CA2880409A1 (OSRAM) |
| MX (1) | MX360120B (OSRAM) |
| SG (1) | SG11201500508XA (OSRAM) |
| WO (1) | WO2014019990A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2914604A1 (en) * | 2013-06-06 | 2014-12-11 | Novartis Ag | Influenza virus reassortment |
| CN104232594B (zh) * | 2014-09-11 | 2017-05-31 | 中国农业科学院哈尔滨兽医研究所 | 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用 |
| US10927151B2 (en) | 2015-06-09 | 2021-02-23 | Sanofi Pasteur Inc. | Methods of optimizing nucleotide sequences encoding engineered influenza proteins |
| CN105754997B (zh) * | 2016-03-30 | 2019-02-26 | 华中农业大学 | 狂犬病毒drv-ah08株的先导rna及其在制备预防与治疗狂犬病毒的药品中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100470180B1 (ko) | 1995-06-15 | 2005-02-04 | 크루셀 홀란드 비.브이. | 유전자 요법에 사용할 수 있는 인간의 재조합아데노바이러스 패키징 시스템 |
| TW389999B (en) | 1995-11-21 | 2000-05-11 | Toshiba Corp | Substrate having shallow trench isolation and method of manufacturing the same |
| US6544785B1 (en) | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
| US8715940B2 (en) | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
| GB9916794D0 (en) * | 1999-07-16 | 1999-09-22 | Isis Innovation | In vitro virus reconstitution |
| GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
| PL205955B1 (pl) | 2000-04-28 | 2010-06-30 | St Jude Childrens Res Hospital | Układ oparty na minimalnej liczbie plazmidów do wytwarzania infekcyjnych wirusów RNA o ujemnej nici, komórka gospodarza zawierająca taki układ, sposób wytwarzania wiriona wirusa RNA o ujemnej nici, sposób wytwarzania atenuowanego wirusa RNA o ujemnej nici, sposób wytwarzania zakaźnego wirusa o ujemnej nici do stosowania w szczepionkach i zastosowanie układu opartego na minimalnej liczbie plazmidów |
| IL158514A0 (en) | 2001-04-23 | 2004-05-12 | Amaxa Gmbh | Buffer solution for electroporation and a method comprising the use of the same |
| AU2004308328B2 (en) | 2003-12-23 | 2009-06-04 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| DE202005022108U1 (de) * | 2004-03-09 | 2013-11-12 | Novartis Vaccines And Diagnostics, Inc. | Influenza-Virus-Impfstoffe |
| ATE382085T1 (de) | 2005-07-07 | 2008-01-15 | Amaxa Ag | Verfahren zur behandlung geringer volumina mit elektrischem strom |
| US20070111309A1 (en) | 2005-10-04 | 2007-05-17 | Daelli Marcelo G | Vero cell line adapted to grow in suspension |
| CN100571775C (zh) | 2006-11-09 | 2009-12-23 | 中国农业科学院哈尔滨兽医研究所 | 禽流感病毒标记疫苗及其制备方法和应用 |
| WO2009152181A1 (en) * | 2008-06-11 | 2009-12-17 | Flugen, Inc. | Cell-based systems for producing influenza vaccines |
| US20110159543A1 (en) | 2008-07-15 | 2011-06-30 | Maartje Verschuur | Scalable process for culturing per.c6 cells and producing products therefrom |
-
2013
- 2013-07-29 CN CN201380051942.6A patent/CN104704112A/zh active Pending
- 2013-07-29 EP EP13742451.1A patent/EP2880154B1/en active Active
- 2013-07-29 WO PCT/EP2013/065920 patent/WO2014019990A1/en not_active Ceased
- 2013-07-29 MX MX2015001499A patent/MX360120B/es active IP Right Grant
- 2013-07-29 CA CA2880409A patent/CA2880409A1/en not_active Abandoned
- 2013-07-29 JP JP2015524755A patent/JP6335167B2/ja not_active Expired - Fee Related
- 2013-07-29 SG SG11201500508XA patent/SG11201500508XA/en unknown
- 2013-07-29 BR BR112015002268A patent/BR112015002268A2/pt not_active Application Discontinuation
- 2013-07-29 US US14/419,235 patent/US9982240B2/en active Active
- 2013-07-29 KR KR1020157004966A patent/KR20150038374A/ko not_active Withdrawn
- 2013-07-29 AU AU2013298632A patent/AU2013298632B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013298632B2 (en) | 2018-11-01 |
| WO2014019990A1 (en) | 2014-02-06 |
| EP2880154A1 (en) | 2015-06-10 |
| CA2880409A1 (en) | 2014-02-06 |
| JP2015530875A (ja) | 2015-10-29 |
| CN104704112A (zh) | 2015-06-10 |
| KR20150038374A (ko) | 2015-04-08 |
| SG11201500508XA (en) | 2015-02-27 |
| AU2013298632A1 (en) | 2015-02-26 |
| US9982240B2 (en) | 2018-05-29 |
| BR112015002268A2 (pt) | 2017-11-07 |
| EP2880154B1 (en) | 2019-05-15 |
| US20150191703A1 (en) | 2015-07-09 |
| JP6335167B2 (ja) | 2018-05-30 |
| MX2015001499A (es) | 2015-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
| PH12015501017A1 (en) | Alternative uses for hbv assembly effectors | |
| EP3201343A4 (en) | High efficiency, high throughput generation of genetically modified mammals by electroporation | |
| PH12013502442A1 (en) | Inactivated dengue virus vaccine | |
| MX372963B (es) | Reordenamiento del virus de influenza b. | |
| MX2017007196A (es) | Fibroblastos de embrion de pollo inmortalizados. | |
| EA201300915A1 (ru) | Новый европейский штамм prrsv | |
| MY173638A (en) | Parainfluenza virus 5 based vaccines | |
| PH12015500040B1 (en) | Supercritical hydrolysis of biomass | |
| WO2013014294A3 (en) | Improved baculovirus expression systems | |
| MX380902B (es) | Métodos para la inactivación viral usando detergentes ecológico. | |
| UA117565C2 (uk) | Модифікований олігонуклеотид | |
| EP2909302A4 (en) | BIOFABRICATION FILAMENT AND METHOD FOR LARGE-SCALE PRODUCTION OF CELLS, VIRUSES AND BIOMOLECULES | |
| PH12016500500A1 (en) | A viral vaccine and methods of manufacture thereof | |
| GB201300017D0 (en) | Micro-electro-mechanical system (MEMS) structures and design structures | |
| MY190659A (en) | Method for producing biohydrocarbons | |
| MX2019011805A (es) | Plantas de melon con resistencia al virus asociado al amarilleamiento del melon (myav). | |
| MX387420B (es) | Producción de virus en cultivos celulares. | |
| BR112015017420A2 (pt) | recombinação de vírus influenza | |
| HUE043096T2 (hu) | Eljárás egy fertõzõ RNS vírus gyors létrehozására | |
| NZ709289A (en) | High resolution melt genotyping of ndv strains | |
| BR112015002268A2 (pt) | produção de vírus influenza infecciosos | |
| MX2015010566A (es) | Metodos para la liberacion de las particulas similares a virus. | |
| EP4008343A3 (en) | Methods and compositions related to increased viral production | |
| MX2015007800A (es) | Co-diferenciacion de los monocitos a partir de donantes alogenicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |